# Discriminator report

## Scenario echo
The scenario is human pancreas, with no cell-type restriction, no specified age or sex, and baseline/healthy condition. There are no notes requiring a special developmental, disease, or pathway-focused structure, so the embedding should cover the expected differentiated pancreatic epithelial, endocrine, stromal, vascular, neural, and resident immune compartments without adding a specialized developmental trajectory.

## Rating: minor
The blueprint covers the major healthy human pancreas compartments well enough to be structurally usable, including acinar, ductal/centroacinar, endocrine islet subtypes, vascular/lymphatic endothelium, mesenchymal/mural cells, immune cells, mast cells, adipocytes, mesothelium, and Schwann/neural cells. Targeted edits are still warranted because a few axes are developmental or redundant for this scenario, and several modules would benefit from cleaner marker specificity.

## Findings

### Minor issues
- **axis:endocrine_precursor_state; axis:multipotent_pancreatic_epithelial_state; module:endocrine_precursor; module:multipotent_pancreatic_epithelium** — Dedicated NEUROG3/INSM1 endocrine precursor and PDX1/PTF1A/SOX9 multipotent progenitor programs are developmentally oriented. With age and notes unspecified, and condition healthy, the expected pancreas landscape should not be shaped around fetal/progenitor states unless the scenario explicitly asks for developmental coverage.
  *Fix:* Remove these two developmental axes and their now-orphan modules, or replace them with mature pancreas-relevant state axes such as ductal/centroacinar specialization or acinar/ductal stress only if biologically justified for healthy baseline data.

- **axis:vascular_endothelial; axis:pan_endothelial_identity; module:pan_endothelial** — `vascular_endothelial` and `pan_endothelial_identity` are near-duplicate plain endothelial dimensions, while `pan_endothelial` is also used as the lymphatic gate despite being mostly blood-endothelial markers. This pads dimensionality and may weaken lymphatic detection.
  *Fix:* Keep one plain blood/pan-endothelial identity axis, delete or repurpose the redundant plain axis, and retune the lymphatic axis so the gate is broadly endothelial or make lymphatic a direct endothelial/lymphatic contrast.

- **module:stellate_matrix_remodeling; axis:stellate_matrix_remodeling_state; axis:pericyte_smooth_muscle_identity** — The stellate/remodeling module is heavily overlapped with mural/smooth-muscle biology (`RGS5`, `PDGFRB`, `DES`, `ACTA2`, `TAGLN`) and is contrasted against a pericyte/smooth-muscle module containing many of the same program genes. In healthy pancreas this may blur pancreatic stellate/fibroblast identity, activated myofibroblast-like state, pericytes, and vascular smooth muscle.
  *Fix:* Retune the stellate/fibroblast side toward ECM/fibroblast or quiescent pancreatic stellate markers, reserve canonical mural genes for pericyte/smooth muscle, and consider separating an activated myofibroblast state only if the baseline dataset is expected to contain it.

- **module:immune_leukocyte** — The leukocyte gate mixes pan-leukocyte markers with myeloid/APC-heavy genes (`LST1`, `HLA-DRA`, `HLA-DPA1`, `HLA-DPB1`, `CD74`, `TYROBP`, `AIF1`). Because this module gates T, NK, B, plasma, mast, macrophage, and dendritic axes, lineage-biased gate genes can suppress non-myeloid immune signals.
  *Fix:* Make the gate more pan-leukocyte using markers such as `PTPRC`, `CORO1A`, `LCP1`, `CD52`, `CD53`, `LAPTM5`, and similar broad immune genes, leaving HLA/TYROBP/LST1 biology to myeloid or antigen-presenting modules.

- **endocrine subtype modules** — The endocrine subtype coverage is good, but several rare-subtype modules rely on shared endocrine transcription factors and prohormone-processing genes more than subtype-specific markers. `DLK1` in the beta-cell module is also more fetal/immature than canonical mature adult beta identity.
  *Fix:* Keep the beta/alpha/delta/PP/epsilon axes, but tighten marker lists around subtype-specific hormone and mature identity genes and remove fetal/immaturity-skewing markers unless an immaturity axis is intentionally added.

## Out of scope (FYI, not actionable for the Generator)
- The blueprint does not need a disease, fibrosis, inflammation, or development gating tree because the scenario notes and condition do not request one.
- Rare circulating granulocytes/neutrophils are not essential for a healthy resident pancreas embedding unless the downstream dataset is known to contain many blood contaminants.

## Summary for the next round
Focus on trimming the developmental progenitor dimensions, collapsing or repurposing the duplicate endothelial identity axis, and retuning marker modules that are currently too lineage-biased or conflated. The differentiated pancreas coverage is otherwise broadly correct, so this should be a targeted cleanup rather than a full redesign.
